BellBrook Labs Awarded Patent on Transcreener® HTS Assay for Glycosyltransferases

5 Jan 2011

Sarah Sarah

Marketing / Sales

Product news

BellBrook Labs announces that they have been awarded a fourth U.S. patent for their innovative line of Transcreener® HTS Assay kits. This new patent, U.S. 7,847,066, describes the invention of a universal assay for UDP-glycosyltransferases based on direct detection of UDP in a high-throughput format.

There are over 200 glycosyltransferases encoded in the human genome that use either UDP-, GDP- or CMP-activated sugars as the donor substrates. UDP-glycosyltransferases are the most abundant and they play a key role in metabolism of drugs. In the Transcreener® UDP Assay, the detection of UDP produced in the enzyme reaction allows for a universal system to measure UDP-glycosyltransferase activity with any acceptor substrate. Because it allows homogenous, mix-and-read detection, the Transcreener® HTS Assay platform offers significant advantages over other assay methods that require separation steps.

In combination with existing Transcreener® assays for GDP and CMP, the newly patented technology will accelerate the discovery of improved drugs targeting glycosylation events in diseases, such as cancer, type II diabetes and neurodegeneration.

Related products

Request Quote for All Products

Transcreener® UDP² Glycosyltransferase Assays
BellBrook Labs
The Transcreener® UDP² Glycosyltransferase Assay Kit directly detects UDP—the conserved product of glycosyltransferase reactions—in a homogeneous mix-and-read format. Compatible with FP, FI, and TR‑FRET readouts, it supports UDP concentrations from 1–250 µM and delivers exceptional HTS performance (Z’ ≥ 0.7) across 96-, 384-, and 1536‑well formats.
(1)
Transcreener® AMP²/GMP² Phosphodiesterase Assays
BellBrook Labs
The Transcreener® AMP²/GMP² Phosphodiesterase Assay Kit directly detects AMP or GMP produced by PDEs, ligases, synthetases, ENPP1, and related enzymes using a mix‑and‑read FP or TR‑FRET format—no coupling steps needed. Compatible with 1–1000 µM native substrates, it delivers excellent HTS performance (Z’ ≥ 0.7, ≥100 mP shift) in a one-step, far‑red fluorescence assay.
(2)
Transcreener® ADP² Kinase Assays
BellBrook Labs
The Transcreener® ADP² Kinase Assay Kit universally detects ADP produced by any kinase or ATPase using a direct mix‑and‑read format, eliminating coupling steps. Available in FP, FI, and TR‑FRET formats with far‑red tracers to minimize interference, it's HTS-ready across 96‑, 384‑, and 1536‑well plates with robust Z' ≥ 0.7 performance.
(3)
Transcreener® GDP GTPase Assays
BellBrook Labs
The Transcreener® GDP GTPase Assay Kit directly measures GDP produced during GTP hydrolysis in a homogeneous mix‑and‑read format—no coupling enzymes needed. Compatible with GTPases, GAPs, and GEFs, it supports FP, FI, and TR‑FRET readouts using far‑red tracers to reduce interference. HTS‑ready with excellent sensitivity (Z′ ≥ 0.7), it streamlines screening and profiling workflows.
(0)